作者:Alamshany, Zahra M.、Nossier, Eman S.
DOI:10.1016/j.molstruc.2024.138973
日期:——
The present study involved the design and synthesis of a novel series of thiazole derivatives 3, 5, 7, 8, 10–13 having various heterocyclic scaffolds, including pyrazole, pyridine, and/or pyrimidine. Upon screening of their antiproliferative efficacy, pyrazolo[3,4-b]pyridine 5a,b and pyrimidine 10a,b, afforded excellent activity against cancerous HepG-2 and MCF-7 cell lines with safety borders against
本研究涉及设计和合成一系列新型噻唑衍生物 3、5、7、8、10-13,具有各种杂环支架,包括吡唑、吡啶和/或嘧啶。在筛选其抗增殖功效后,吡唑并[3,4-b]吡啶 5a,b 和嘧啶 10a,b 对癌性 HepG-2 和 MCF-7 细胞系具有优异的活性,与正常人二倍体细胞系 WI-38 相比,与阿霉素和厄洛替尼相比,安全边界。然后,它们对凋亡指标的影响;评估 caspase-3 、 Bax 和 Bcl-2。在抗菌活性方面,除白色念珠菌外,所有筛选的革兰氏阳性和革兰氏阴性细菌和真菌菌株均被带有吡唑并[3,4-b]吡啶 5a,b 和嘧啶 10a,b 的噻唑部分有效抑制。此外,噻唑-吡唑并[3,4-b]吡啶5b对EGFR和大肠杆菌DNA旋转酶表现出显著且优越的抑制性能(IC50 = 0.35 ± 0.25和2.55 ± 0.03 μM),与参考文献厄洛替尼和新生霉素相比 (IC50 = 0.27 ±